4.8 Article

Advances in carbon nanomaterials for immunotherapy

Journal

APPLIED MATERIALS TODAY
Volume 27, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.apmt.2022.101397

Keywords

Carbon nanomaterials; Immunotherapy; Immune cells; Drug delivery; Cancer; Inflammation; Autoimmune diseases

Funding

  1. national funds through the FCT/MCTES (PIDDAC) [UIDP/00511/2020]
  2. Institute for Research and Innovation in Health-i3S [UIDB/04293/2020]
  3. FEDER funds
  4. national funds (PIDDAC) through FCT/MCTES [POCI-01-0145-FEDER-031143]
  5. Portuguese Foundation for Science and Technology (FCT) [NORTE-01-0145-FEDER-000054]
  6. Norte Portugal Regional Operational Programme
  7. European Regional Development Fund (ERDF) [CEECIND/03908/2017]
  8. Portuguese Foundation for Science and Technology (FCT)
  9. [UIDB/00511/2020]
  10. Fundação para a Ciência e a Tecnologia [UIDP/00511/2020, UIDB/00511/2020] Funding Source: FCT

Ask authors/readers for more resources

Remarkable progress has been made in the field of nanomedicine and immunotherapy, particularly in the use of carbon nanomaterials for cancer treatment and immunomodulation. These materials offer various advantages and have the potential to revolutionize biomedical research. However, further improvements and translation to clinical applications are still required.
Remarkable advances have been achieved in the field of nanomedicine and immunotherapy, since it was found that several nanomaterials can modulate the immune system. The main objective of this review is to collect and discuss studies where carbon nanomaterials (CNM), due to their unique structure and composition, revealed to be important tools in cancer treatment, immunostimulation, and immunosuppression of inflammatory or autoimmune diseases. These materials offer several advantages, such as being effective platforms for drug delivery and targeting, immunomodulation, phototherapy, and others. Some effects still need to be upgraded and some questions persist. Positive results were already achieved, although translation to clinics is still needed. The evolution of future investigations may still revolutionize the field of biomedicine.(c) 2022 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available